NCT06460298 2025-08-12ProAgio in Combination With Gemcitabine in Patients With Metastatic Triple Negative Breast CancerProDa BioTech, LLCPhase 1/2 Recruiting51 enrolled
NCT02632448 2025-05-02A Study of LY2880070 in Participants With Advanced or Metastatic CancerEsperas Pharma Inc.Phase 1/2 Completed229 enrolled
NCT03997968 2024-12-24A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid TumorsCyteir Therapeutics, Inc.Phase 1/2 Completed169 enrolled
NCT01939418 2017-10-03Phase Ib/II Trials of RAD001 in Triple Negative Metastatic Breast CancerNational Cancer Center, KoreaPhase 1/2 Terminated23 enrolled